|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.555
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.504
|
Human |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.483
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.453
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.422
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.376
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.368
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.362
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.342
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.309
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.308
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.294
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.273
|
Human |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.273
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.258
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.258
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.257
|
Fly |
|
|
learning
|
GO:0007612 |
98 |
0.247
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.238
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.237
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.234
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.223
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.222
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.218
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.215
|
Human |
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.214
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.212
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.212
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.205
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.205
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.202
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.197
|
Human |
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.196
|
|
|
|
axonal fasciculation
|
GO:0007413 |
15 |
0.191
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.187
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.184
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.180
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.171
|
Fly |
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.169
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.166
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.165
|
Mouse |
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.164
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.163
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.162
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.159
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.158
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.157
|
Human |
|
|
adult behavior
|
GO:0030534 |
135 |
0.155
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.152
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.151
|
Fly |
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.151
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.148
|
|
|
|
maintenance of presynaptic active zone structure
|
GO:0048790 |
1 |
0.147
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.147
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.141
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.140
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.138
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.138
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.136
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.136
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.135
|
Mouse |
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.135
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.135
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.134
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.134
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.133
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.132
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.132
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.131
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.130
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.128
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.125
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.125
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.124
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.124
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.122
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.122
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.121
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.120
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.118
|
|
|
|
regulation of terminal button organization
|
GO:2000331 |
1 |
0.117
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.117
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.115
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.113
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.112
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.108
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.107
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.107
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.106
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.106
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.105
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.102
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.101
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.096
|
Mouse |
|
|
gland development
|
GO:0048732 |
330 |
0.096
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.095
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.094
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.092
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.092
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.092
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.092
|
Human |
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.092
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.091
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.089
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.089
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.089
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.088
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.087
|
|
|
|
neural fold elevation formation
|
GO:0021502 |
1 |
0.087
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.086
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.085
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.085
|
Human |
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.085
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.084
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.084
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.084
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.082
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.082
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.080
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.080
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.079
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.079
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.079
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.079
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.076
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.076
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.076
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.076
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.076
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.075
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.075
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.075
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.074
|
Human |
|
|
heart process
|
GO:0003015 |
94 |
0.073
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.073
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.073
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.073
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.072
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.072
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.071
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.070
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.070
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.070
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.070
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.069
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.069
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.069
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.068
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.068
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.067
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.066
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.066
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.066
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.066
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.065
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.065
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.065
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.064
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.064
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.064
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.064
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.063
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.063
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.063
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.062
|
|
|
|
terminal button organization
|
GO:0072553 |
3 |
0.062
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.062
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.062
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.062
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.061
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.061
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.061
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.059
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.059
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.059
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.059
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.058
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.058
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.058
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.057
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.057
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.057
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.057
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.056
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.056
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.056
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.056
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.055
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.055
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.055
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.055
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.054
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.054
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.054
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.053
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.053
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.053
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.053
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.052
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.052
|
|
|
|
connective tissue replacement involved in inflammatory response wound healing
|
GO:0002248 |
3 |
0.051
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.051
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.051
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.051
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.051
|
Human |
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.051
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.051
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.051
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.051
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.051
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.050
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.050
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.050
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.049
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.049
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.049
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.049
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.049
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.049
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.049
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.049
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.049
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.049
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.048
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.048
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.048
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.047
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.047
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.047
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.047
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.047
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.047
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.047
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.046
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.046
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.046
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.046
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.046
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.045
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.045
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.045
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.045
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.045
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.045
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.044
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.044
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.044
|
Mouse |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.044
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.044
|
Human |
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.044
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.044
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.044
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.043
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.043
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.043
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.043
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.043
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.043
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.042
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.042
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.042
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.042
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.042
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.041
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.041
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.041
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.041
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.041
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.041
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
2 |
0.041
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.041
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.041
|
|
|
|
phosphatidylethanolamine metabolic process
|
GO:0046337 |
2 |
0.041
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.041
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.040
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.040
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.040
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.040
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.040
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.040
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.039
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.039
|
Human |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.038
|
|
|
|
l glutamate import into cell
|
GO:1990123 |
3 |
0.038
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.038
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.038
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.038
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.038
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.037
|
|
|
|
l glutamate uptake involved in synaptic transmission
|
GO:0051935 |
3 |
0.037
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.037
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.037
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.037
|
Mouse |
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.037
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.037
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.037
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.036
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.036
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.036
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.036
|
|
|
|
regulation of high voltage gated calcium channel activity
|
GO:1901841 |
2 |
0.036
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.036
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.036
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.036
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.036
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.036
|
|
|
|
gamma aminobutyric acid transport
|
GO:0015812 |
7 |
0.035
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.035
|
Fly |
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.035
|
|
|
|
visual learning
|
GO:0008542 |
44 |
0.035
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.035
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.035
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.035
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.035
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.034
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.034
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.034
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.034
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.034
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.034
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.033
|
Human |
|
|
male gonad development
|
GO:0008584 |
88 |
0.033
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.033
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.033
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.033
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.033
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.033
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.033
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.033
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.033
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.032
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.032
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.032
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.032
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.032
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.032
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.032
|
|
|
|
lung pattern specification process
|
GO:0060432 |
1 |
0.032
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.032
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.031
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.031
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.031
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.031
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.031
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.031
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.031
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.031
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.031
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.031
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.031
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.031
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.031
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.031
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.030
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.030
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.030
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.030
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.030
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.030
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.029
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.029
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.029
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.029
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.029
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.029
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.029
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.029
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.029
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.029
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.029
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.029
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.029
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.028
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.028
|
|
|
|
amino acid import into cell
|
GO:1902837 |
4 |
0.028
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.028
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.028
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.028
|
|
|
|
translation
|
GO:0006412 |
93 |
0.028
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.028
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.028
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.028
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.028
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.028
|
|
|
|
left right pattern formation
|
GO:0060972 |
23 |
0.028
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.027
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.027
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.027
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
11 |
0.027
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.027
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.027
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.027
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.027
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.027
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.027
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.027
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.027
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.027
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.027
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.027
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.027
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.027
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.027
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.026
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.026
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.026
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.026
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.026
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.026
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.026
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.026
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.026
|
|
|
|
protein localization to synapse
|
GO:0035418 |
11 |
0.026
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.026
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.026
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.026
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.026
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.026
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.026
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.026
|
Human |
|
|
stem cell division
|
GO:0017145 |
30 |
0.026
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.026
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.026
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.026
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.025
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.025
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.025
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.025
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.025
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.025
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.025
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.025
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.025
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.025
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.025
|
|
|
|
regulation of resting membrane potential
|
GO:0060075 |
3 |
0.025
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.025
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.025
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.025
|
Human |
|
|
gamma aminobutyric acid secretion
|
GO:0014051 |
6 |
0.025
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.025
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.025
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.025
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.025
|
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.025
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.024
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.024
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.024
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.023
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.023
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.023
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.023
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.023
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.023
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.023
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.023
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.023
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.023
|
Human |
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.023
|
|
|
|
ventricular system development
|
GO:0021591 |
27 |
0.023
|
|
|
|
regulation of alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor activity
|
GO:2000311 |
11 |
0.022
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.022
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.022
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.022
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.022
|
Fly |
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.022
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.022
|
|
|
|
b 1 b cell homeostasis
|
GO:0001922 |
4 |
0.022
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.022
|
Human |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.022
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.022
|
|
|
|
positive regulation of membrane potential
|
GO:0045838 |
15 |
0.022
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.022
|
Human |
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.022
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.022
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.022
|
|
|
|
potassium ion import
|
GO:0010107 |
1 |
0.022
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.021
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.021
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.021
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.021
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.021
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.021
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.021
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.021
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.021
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.021
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.021
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.021
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.021
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.021
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.021
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.021
|
|
